• The prestigious award Governors Award for Excellence was bestowed by the Hon’ble Governor of West Bengal, Dr. C.V Ananda Bose
• The Hon’ble Governor during his visit to Aster Medcity, Kochi also launched the cutting-edge CAR-T Cell Therapy medical programme

 Ms. Alisha Moopen, Deputy Managing Director, Aster DM Healthcare, was bestowed with the prestigious “Pravasi Bhushan” Award by the Hon’ble Governor of West Bengal, Dr. C.V Ananda Bose. The award was presented on November 08, 2024 at Aster Medcity in Kochi. The esteemed award highlights her impactful leadership and enduring commitment to advancing healthcare, both in India and internationally, enhancing accessibility and quality of care for millions. Alongside the notable recognition, Aster Medcity also launched the groundbreaking CAR-T Cell Therapy Programme, for blood cancer treatment. The inauguration, led by Honourable Governor Dr. C.V Ananda Bose, was attended by MP Hibi Eden, Ms. Alisha Moopen, Mr. Anoop Moopen, and senior leadership and doctors from Aster.

The distinguished award recognizes Ms. Moopen’s exceptional contributions to the healthcare sector. Since joining the company in 2013, Alisha has played a key role in shaping its strategic direction and growth, while leading the group’s expansion into new markets. Today, Aster DM Healthcare is one of the largest healthcare service providers operating in India and provides the complete circle of care through its primary, secondary, tertiary and quaternary care services. Today, Aster DM Healthcare through its world-class healthcare services serves millions across geographies and provides direct employment to over 17,000+ people which includes approximately 1,828 doctors and 6,330 nurses.

Ms. Moopen completed her chartered accountancy from the ICAS (Institute of Chartered Accountants of Scotland) and was working as a Chartered Accountant at Ernst & Young before joining Aster. She is also a distinguished alumna of University of Michigan, Ann Arbor with a distinction in Finance & Accounting. She also holds a degree in Global Leadership & Public Policy Change from Harvard University.  Over the years, Ms. Moopen has won several prestigious awards and accolades on the global stage. She has been responsible for managing the strategic direction and development of the company, alongside spearheading the expansion of the group into new markets.

Ms. Alisha Moopen, Deputy Managing Director, Aster DM Healthcare, said, “I am deeply honored to receive the Pravasi Bhushan Award from His Excellency, Dr. Ananda Bose, Hon’ble Governor of West Bengal. This recognition not only reflects our team’s unwavering commitment to patient care and fostering innovation but also honors the vision and relentless hard work of our Chairman, Dr. Azad Moopen, who built Aster from a single clinic into a global healthcare conglomerate in a span of just three decades. His journey inspires us every day to strive for excellence and make quality healthcare accessible to all. I am grateful for this acknowledgment and remain committed to carrying forward this legacy.”

Further talking on the launch of the cutting-edge treatment, Ms. Moopen added, “CAR T-cell therapy is a major breakthrough in the treatment of leukemia and B cell lymphoma, particularly for patients who have relapsed or are unresponsive to conventional treatments. Due to the complexity, high costs, and specialized infrastructure required, CAR T-cell therapy is often limited to a few centers.  With the launch of this programme, Aster Medcity aims to provide world-class, accessible, and cutting-edge cancer treatment options, thus significantly easing the financial and logistical burdens on patients.”

Aster DM Healthcare is transforming the cancer treatment landscape with the Aster International Institute of Oncology, supported by the recently launched IOeRT treatment at Aster Whitefield, Bangalore and the CAR-T cell therapy at Aster Medcity, Kochi. These initiatives reinforce Aster DM Healthcare’s commitment to providing quality & accessible healthcare to the people of India, through the use of technology enabling better health outcomes for population management through precision medicine, connected care and AI.